Abstract:Background: Liver is one of the most preferred destinations of distant metastasis in gastric cancer (GC). As effective treatment is still limited, the prognosis of GC patients bearing liver metastasis is poor. We filter out lysyl oxidase (LOX) to study its function in the tumor microenvironment (TME) and seek for potential therapeutic targets.Methods: Transcription analysis on 6 cases of liver metastasis of GC patients with respective paired primary tumors and adjacent normal livers was performed. The filtration out of LOX was done using 5 datasets. 69 GC liver metastasis tissues were utilized to perform immunohistochemistry (IHC) and analyze prognosis. Computed Tomography (CT) combined 3D organ reconstruction bioluminescence imaging was performed to precisely evaluate the metastatic tumor burden on liver of intrasplenic injection mouse model. Human and mouse cancer associated fibroblasts (CAFs) in liver metastasis were separated to culture to study the interaction of LOX and TGF-β1. Patients-derived xenograft (PDX) model was established using liver metastasis of patients to evaluate the therapeutic value of LOX inhibitor β‐aminopropionitrile (BAPN).Results: CAFs-derived LOX at liver metastatic niche of GC promotes niche formation and outgrowth thus predicts poor prognosis. Meanwhile tumor cells in niche secrete TGF-β1 to nourish CAFs and stimulate them to produce more LOX in turn. The mechanism involved in LOX-mediated proliferation facilitation is enhancement of Warburg effect. The inhibitor of LOX, BPAN could hamper the effect brought by LOX in vivo and in vitro.Interpretation: Our study has unveiled a positive feedback loop between CAFs and tumor cells in liver metastasis niche of GC. The core molecule is LOX which facilitates Warburg effect. Targeting LOX with its inhibitor BAPN might serve as a potential therapeutic strategy.Funding Statement: This research is supported by the national natural science foundation of China (31872740), The 100-member plan of the Shanghai municipal commission of health and family planning (2017BR043), Shanghai science and technology commission project (17ZR1416800), Renji hospital training fund (PYMDT-003, PYIII-17-015). National Natural Science Foundation of China (81672358, to Z.-G. Zhang), the Shanghai Municipal Education Commission—Gaofeng Clinical Medicine Grant Support (20181708, to Z.-G. Zhang), Program of Shanghai Academic/Technology Research Leader (19XD1403400, to Z.-G. Zhang), Science and Technology Commission of Shanghai Municipality (18410721000, to Z.-G. Zhang) and Shanghai Municipal Health Bureau (2018BR32, to Z.-G. Zhang). National Natural Science Foundation of China, No. 81701945.Declaration of Interests: The authors declare no conflict of interest.Ethics Approval Statement: The whole process of specimen collection and experiment performance were approved by the local ethics committee in Renji Hospital, with all patients’ informed consents.

Secreted Loxl2 Is A Novel Therapeutic Target That Promotes Gastric Cancer Metastasis Via The Src/Fak Pathway

Lysyl Oxidase-Like Protein 2 Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer

LOXL 2 Promotes The Epithelial–Mesenchymal Transition And Malignant Progression Of Cervical Cancer

Lysyl Oxidase Promotes Liver Metastasis of Gastric Cancer Via Facilitating the Reciprocal Interactions Between Tumor Cells and Cancer Associated Fibroblasts.

LOXL2 Upregulates Hypoxia‑inducible Factor‑1α Signaling Through Snail‑FBP1 Axis in Hepatocellular Carcinoma Cells.

Lysyl Oxidase-Like 4 (LOXL4) Promotes Proliferation and Metastasis of Gastric Cancer Via FAK/Src Pathway.

Lymphatic Endothelial Cell-Secreted Cxcl1 Stimulates Lymphangiogenesis and Metastasis of Gastric Cancer

Lectin-like oxidized low-density lipoprotein receptor-1 facilitates metastasis of gastric cancer through driving epithelial-mesenchymal transition and PI3K/Akt/GSK3β activation

lncRNA/miR-29c-Mediated High Expression of LOX Can Influence the Immune Status and Chemosensitivity and Can Forecast the Poor Prognosis of Gastric Cancer

LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma.

Lysyl oxidase‐like 2 promotes stemness and enhances antitumor effects of gefitinib in head and neck cancer via IFIT1 and IFIT3

Upregulated Expression of LOX is a Novel Independent Prognostic Marker of Worse Outcome in Gastric Cancer Patients after Curative Surgery.

A truncated splice variant of human lysyl oxidase-like 2 promotes migration and invasion in esophageal squamous cell carcinoma

Lysyl Oxidase Enhances Warburg Effect to Mediate Reciprocal Interactions Between Tumor Cells and Cancer Associated Fibroblasts in Liver Metastasis of Gastric Cancer

OxLDL Promotes Lymphangiogenesis and Lymphatic Metastasis in Gastric Cancer by Upregulating VEGF‑C Expression and Secretion.

Long noncoding RNA lnc-LEMGC combines with DNA-PKcs to suppress gastric cancer metastasis

LOXL3 Silencing Hampers the Metastasis and Angiogenesis of Gastric Cancer Cells Dependent on Ferroptosis Activation

Exosome-mediated Secretion of LOXL4 Promotes Hepatocellular Carcinoma Cell Invasion and Metastasis.

Lysyl oxidase: A colorectal cancer biomarker of lung and hepatic metastasis.

Lysyl oxidase may play a critical role in hypoxia-induced NSCLC cells invasion and migration.

Long Non-coding RNA LOXL1-AS1 Drives Breast Cancer Invasion and Metastasis by Antagonizing Mir-708-5p Expression and Activity